Breadcrumb
Recerca i Innovació Què fem Equip
Investigadors - Títol

Recerca - El nostre equip

PeopleCategories
People
Javier Louro

Javier Louro

Assistant Research Professor Medi ambient i salut al llarg de la vida

Javier Louro is an Assistant Research Professor at ISGlobal working through a framework agreement within the Epidemiology Unit of Hospital del Mar.

He holds a BSc in Mathematics (University of Santiago de Compostela - USC, 2014), an MSc in Statistics and Operations Research (Polytechnic University of Catalonia - UPC, 2016), a Postgraduate Expert in Health Services Research and Chronic Diseases (University of Alcalá - UAH, 2017), and a PhD in Methodology of Biomedical Research and Public Health (Autonomous University of Barcelona - UAB, 2021).

Louro previously worked at Hospital del Mar Research Institute (IMIM) as a PhD researcher (2016–2021) and as a postdoctoral researcher and project manager (2021–2023), and worked at Karolinska Institutet (KI) as a postdoctoral researcher and teacher (2023–2026), where he secured competitive grant funding as a Principal Investigator. He has authored over 40 peer-reviewed papers (h-index: 16) and has over 500 hours of teaching experience, which led to his ANECA accreditation as an Associate Professor.

His research focuses on cancer epidemiology, with key contributions in breast, colorectal, pediatric, and cancer screening research. Currently, his main line of research centers on early-onset breast cancer, specifically investigating the role of the exposome behind the increase in incidence among women under 50.

Línies de recerca

  • Cancer Epidemiology
  • Cancer Screening
  • Early-onset Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Childhood Cancer
  • Inequalities in Diagnosis

Publicacions principals

  • Louro J, et al., Tettamanti G. COVID-19 infection and severity among childhood cancer survivors in Denmark and Sweden: a register-based cohort study with matched population and sibling comparisons. Lancet Reg Health Eur. 2025 Jul 4;55:101363. doi: 10.1016/j.lanepe.2025.101363. IF: 15.7 (Q1 - Public, Environmental and Occupational Health).
  • Louro J,et al., Sala M. A systematic review and quality assessment of individualised breast cancer risk prediction models. Br J Cancer. 2019 Jul;121(1):76-85. doi: 10.1038/s41416-019-0476-8. Epub 2019 May 22. IF: 5.8 (Q1 - Oncology).
  • Louro J, et al., Hofvind S. Personalized Breast Cancer Screening: A Risk Prediction Model Based on Women Attending BreastScreen Norway. Cancers (Basel). 2023 Sep 12;15(18):4517. doi: 10.3390/cancers15184517. IF: 4.5 (Q1 - Oncology).
  • Kampitsi CE*, Louro J*,et al., Tettamanti G. Childhood cancer in Sweden during the COVID-19 pandemic: Temporal patterns in incidence and survival in a nationwide register-based cohort study. PLoS Med. 2026 Mar 5;23(3):e1004934. doi: 10.1371/journal.pmed.1004934. *Contributed equally. IF: 9.9 (Q1 - Medicine general & internal). 
  • ReiBinger J, et al., Louro J. Socioeconomic differences in primary healthcare use before childhood cancer diagnosis: a register-based cohort study in Sweden. BMJ Paediatr Open. 2026 Sep 24;10(1):e005059. doi: 10.1136/bmjpo-2026-005059. IF: 2.6 (Q1 - Pediatrics).
Publicador de continguts